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Abstract
Cartilage has limited self-regenerative capacity. Tissue 
engineering can offer promising solutions for reconstruction 
of missing or damaged cartilage. A major challenge herein 
is to define an appropriate cell source that is capable of 
generating a stable and functional matrix. This study 
evaluated the performance of culture-expanded human 
chondrocytes from ear (EC), nose (NC) and articular joint 
(AC), as well as bone-marrow-derived and adipose-tissue-
derived mesenchymal stem cells both in vitro and in vivo. 
All cells (≥ 3 donors per source) were culture-expanded, 
encapsulated in alginate and cultured for 5 weeks. 
Subsequently, constructs were implanted subcutaneously 
for 8 additional weeks. Before and after implantation, 
glycosaminoglycan (GAG) and collagen content were 
measured using biochemical assays. Mechanical properties 
were determined using stress-strain-indentation tests. 
Hypertrophic differentiation was evaluated with qRT-PCR 
and subsequent endochondral ossification with histology. 
ACs had higher chondrogenic potential in vitro than the 
other cell sources, as assessed by gene expression and GAG 
content (p < 0.001). However, after implantation, ACs did 
not further increase their matrix. In contrast, ECs and NCs 
continued producing matrix in vivo leading to higher GAG 
content (p < 0.001) and elastic modulus. For NC-constructs, 
matrix-deposition was associated with the elastic modulus 
(R2 = 0.477, p = 0.039). Although all cells – except ACs – 
expressed markers for hypertrophic differentiation in vitro, 
there was no bone formed in vivo. Our work shows that 
cartilage formation and functionality depends on the cell 
source used. ACs possess the highest chondrogenic capacity 
in vitro, while ECs and NCs are most potent in vivo, making 
them attractive cell sources for cartilage repair.
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Cartilage is a highly specialised avascular connective 
tissue located at a variety of anatomical locations such as 
the ear, nose, trachea, ribs and articular joints. In general, 
cartilage predominantly consists of an extracellular matrix 
(ECM), which is produced, maintained and remodelled 
by a relatively small number of specialised cells (1-10 %) 
(Muir, 1995). The exact composition of the ECM is mainly 
dependent on the tissue’s function and thus three major 
subtypes can be distinguished: hyaline, fibrous and elastic 
cartilage. It is well known that due to its avascular origin, 
cartilage itself has a limited self-regenerative capacity. As 
a result, cartilage defects can lead to severe pain, disability 
and aesthetic impairment. Currently, surgical repair of 
cartilage requires either autogeneic cartilage grafts or 
artificial material implants. However, these conventional 
treatments are (1) associated with a limited availability 
of autogeneic tissue, (2) can cause donor site morbidity, 
and – in the case of artificial implants – (3) are prone to 
generate a foreign body reaction.
 To overcome these problems, tissue engineering 
(TE) can offer a promising solution for restoring missing 
or damaged cartilage. TE-approaches have focused on 
the production of functional cartilage that has features 
similar to native tissue. In cartilage TE, small tissue 
biopsies are harvested, thus generating minimal donor 
site morbidity. Cells are isolated from the biopsies 
and stimulated to proliferate in culture providing large 
quantities of cells. These cells are subsequently stimulated 
to produce cartilage tissue which should structurally and 
morphologically resemble native tissue. One of the major 
challenges in cartilage TE is defining an appropriate cell 
source. The most obvious cell source is cartilage itself. 
Hyaline articular cartilage is most frequently used for 
cartilage TE, although some experiments have been 
published on the use of non-articular cartilages (e.g. 
nasal, ear and costal cartilage) (Stoddart et al., 2009). 
Next to chondrocytes, mesenchymal stem cells (MSCs) 
with their multi-lineage differentiation potential and easy 
availability from bone marrow or adipose tissue have been 
demonstrated as an attractive cell source for cartilage TE 
(Johnstone et al., 1998; Pittenger et al., 1999).
 To date, we and others have evaluated the use of 
chondrocytes and MSCs of several anatomical locations 
for their applicability in cartilage regenerative medicine 
(Afizah et al., 2007; Asawa et al., 2009; Chung et al., 
2008; Hellingman et al., 2011; Henderson et al., 2007; 
Isogai et al., 2006; Johnson et al., 2004; Kafienah et al., 
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2002; Karlsson et al., 2007; Kusuhara et al., 2009; Lohan 
et al., 2011; Malicev et al., 2009; Naumann et al., 2004; 
Panossian et al., 2001; Sakaguchi et al., 2005; Seda Tigli et 
al., 2009; Tay et al., 2004; van Osch et al., 2004; Vinardell 
et al., 2012; Xu et al., 2004; Yoshimura et al., 2007; Zhang 
and Spector, 2009). However, precise comparison of the 
performance of culture-expanded human cells is lacking. 
This knowledge is important to be able to select an optimal 
cell source for each application of cartilage TE. The 
current study was designed to evaluate the performance of 
culture-expanded cells of several sources for generating a 
stable and functional ECM in vitro and in vivo. Therefore, 
human chondrocytes from ear, nose and articular joint and 
MSCs derived from bone marrow and adipose tissue were 
compared. Cartilage matrix production was evaluated 
using qRT-PCR and biochemical assays during in vitro 
culture. Biochemical assays, histology and mechanical tests 
were used to determine tissue stability and functionality 




Ear (EC: n = 5, median age 69, range 17-75 years) and nasal 
cartilage (NC: n = 8, median age 24, range 18-46 years) 
were obtained from patients undergoing reconstructive 
subtotal septorhinoplasty. For articular cartilage (AC), 
both healthy (n = 2, traumatic amputation) and diseased 
knee cartilage (n = 7, osteoarthritis) were harvested. 
Since no clear differences in chondrogenic potential 
were visible between both healthy and diseased AC (data 
not shown), we combined them for further experiments 
(total n = 9, median age 68, range 43-88 years). To obtain 
adipose-tissue-derived mesenchymal stem cells (aMSC), 
subcutaneous abdominal adipose tissue was used from 
patients undergoing reconstructive breast surgery (n = 7, 
median age 51, range 34-71 years). All these tissue samples 
were obtained as waste material after surgery with approval 
of the local medical ethics committee (MEC-2011-371). 
Finally, bone marrow-derived mesenchymal stem cells 
(bMSC) were harvested from femoral shaft biopsies during 
total hip replacement surgery, after informed consent had 
been acquired and with approval of the local medical 
ethics committee (MEC-2004-142) (n = 11, median age 
63, range 39-72 years).
Cell isolation and culture
Expansion
To isolate chondrocytes, macroscopically intact cartilage 
pieces were washed after careful resection of the 
perichondrium (in the case of nasal and ear cartilage). 
Cartilage pieces were diced into small fragments and 
incubated for 1 h with protease (2 mg/mL; Sigma-Aldrich, 
St. Louis, MO, USA), followed by overnight incubation 
with collagenase B (Roche Diagnostics, Mannheim, 
Germany) in high glucose (4.5 g/L) Dulbecco’s modified 
Eagle’s medium (HG-DMEM; Gibco, Carlsbad, CA, 
USA) with 10 % foetal calf serum (FCS; Gibco), 50 µg/
mL gentamycin (Gibco), and 0.5 µg/mL amphotericin B 
(Fungizone; Life Technologies, Breda, the Netherlands). 
To remove small parts of undigested cartilage, the cell 
suspension was filtered through a nylon 100 µm mesh. Prior 
to cell seeding, cell viability was tested using the trypan 
blue exclusion test, and cell number was calculated with a 
haemocytometer. Chondrocytes were finally seeded at an 
initial density of 7500 cells/cm2 in ‘standard chondrocyte 
expansion medium’ containing HG-DMEM supplemented 
with 10 % FCS, 50 µg/mL gentamycin, and 0.5 µg/mL 
Fungizone.
 Bone-marrow-derived heparinised aspirates were 
seeded at a density of 2-5 x 105 nucleated cells/cm2 and 
cultured overnight in ‘standard MSC expansion medium’ 
containing low glucose (1.5 g/L) Dulbecco’s modified 
Eagle’s medium (LG-DMEM), supplemented with 10 % 
FCS; 50 µg/mL gentamycin; 0.5 µg/mL Fungizone; 10-4 M 
L-ascorbic acid 2-phosphate (Sigma-Aldrich); and 1 ng/mL 
basic Fibroblast Growth Factor 2 (bFGF2; AbD Serotec, 
Kidlington, UK). After 24 h, non-adherent cells and cell 
debris were washed out and adherent bMSC were further 
expanded using ‘standard MSC expansion medium’.
 To extract aMSCs, excised human adipose tissue 
was washed with LG-DMEM, minced, and suspended in 
0.1 % collagenase type I solution (Invitrogen, Carlsbad, 
CA, USA) in the presence of 1 % bovine serum albumin 
(BSA; PAA Laboratories Gmbh, Cölbe, Germany) in 
LG-DMEM. After 60 min of enzymatic digestion on an 
orbital shaker, floating adipocytes were separated from 
the precipitating MSC fraction by centrifugation (10 min, 
1500 RPM), washed with ‘standard MSC expansion 
medium’, and filtered through a 100 μm nylon mesh. 
Before cell seeding, the amount of nucleated cells was 
assessed using methylene blue, and cell number was 
calculated with a haemocytometer. The cell suspension 
was seeded at an initial density of 40,000 cells/cm2 in 
‘standard MSC expansion medium’.
 All cells were cultured at 37 °C in air containing 5 % 
carbon dioxide. Medium was changed twice a week. When 
cell cultures reached 80 % confluence, chondrocytes and 
MSCs were trypsinised using 0.05 % trypsin-EDTA. 
Chondrocytes were seeded at a 7500 cells/cm2 and MSCs 
at a 2300 cells/cm2 cell density for further expansion 
to increase cell number. All third-passage (P3) cells 
which were approaching subconfluence were detached 
and cultured in a three-dimensional alginate system (as 
described below) to promote chondrogenesis.
 In order to determine the proliferation rate of cultured 
ECs, NCs, ACs, bMSCs and aMSCs, growth kinetics 
of three donors from each cell source were evaluated in 
monolayer expansion using the number of population 
doublings (PD) until subconfluency and the time to reach 
passage four. Therefore, we have calculated the PD/D 
(Population Doublings per Day) by using the formula: 
PD/D = (ln(N2/N1)/ln (2))/D; where N1 was the number 
of cells at the beginning of each passage, N2 the number of 
cells at subconfluency, and D the number of days to reach 
passage four.
Chondrogenic differentiation
For three-dimensional alginate culture, isolated cells from 
four donors of each cartilage source and six donors from 
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each of the MSC-sources were suspended at a density 
of 4 x 106 cells/mL in clinical grade 1.1 % low viscosity 
alginate solution dissolved in 0.9 % NaCl (Batch MG-
004, CellMed, Alzenau, Germany). Afterwards, the 
cell-alginate mixture was transferred into a 10 mL sterile 
syringe from which the suspension was slowly passed 
through a 23-gauge needle to produce drops, which fell 
into a 102 mM CaCl2 solution. Following instantaneous 
gelation, the beads were allowed to further gelate for a 
period of 10 min in the CaCl2 solution. After being washed 
once with 0.9 % NaCl and HG-DMEM, the beads were 
transferred to 24-well plates. Controls were cultured in 
150 μL/bead ‘control differentiation medium’ containing 
serum-free HG-DMEM supplemented with 50 µg/mL 
gentamycin; 0.5 µg/mL Fungizone; 1 mM sodium pyruvate 
(Gibco); 40 μg/mL L-proline (Sigma-Aldrich); insulin 
transferrin selenium (ITS+; B&D Bioscience, Bedford, 
MA, USA); 10-7 M dexamethasone (Sigma-Aldrich); and 
25 μg/mL L-ascorbic acid 2-phosphate. In the experimental 
condition (‘chondrogenic differentiation medium’), 
10 ng/mL transforming growth factor β1 (TGFβ1; R&D 
Systems, Minneapolis, MN, USA) was added to induce 
chondrogenesis. Medium was changed twice a week. 
After two and five weeks, alginate beads were processed 
for biochemical or gene-expression analysis as described 
below. For all in vitro experiments, four donors for the 
chondrocyte sources and six donors for the MSC sources 
were used, with at least duplicate samples per analyses for 
each individual donor.
 To study in vivo functionality and stability of cartilage 
TE constructs after in vitro cell culture, larger flat constructs 
were created from cells of three donors of each cell source 
as previously described (Wong et al., 2001). In short, 
alginate suspensions containing 4 x 106 cells/mL were 
injected into a custom-designed slab mould consisting of 
two calcium-permeable membranes (Durapore® 5.0 μm 
membrane filters, Millipore, Amsterdam, the Netherlands) 
rigidly supported by stainless-steel meshes and separated 
by a stainless-steel casting frame. Part of these constructs 
were harvested after five weeks of cell culture for analysis 
and a part was implanted subcutaneously on the dorsal 
side of athymic mice. For the in vivo experiments, a total 
of six constructs per cell source were used, with duplicate 
samples for three different donors.
Subcutaneous implantation in vivo
In total, seventeen nine-week old, female NMRI nu/























Table 1. Sequences of primers and probes for qRT-PCR.
Scoring categories Score
(1) Uniformity and darkness of the stain
No stain 0
Weak stain of poorly formed matrix 1
Moderately even stain 2
Even dark stain 3
(2) Distance between cells / amount of matrix accumulated
High cell densities with no matrix in between (no spacing between cells) 0
High cell densities with little matrix in between (cells <1 cell-size apart) 1
Moderate cell density with matrix (cells approximately 1 cell-size apart) 2
Low cell density with moderate distance between cells (>1 cell) and an extensive matrix 3
(3) Cell morphologies represented
Condensed/necrotic/pycnotic bodies 0
Spindle/fibrous 1
Mixed spindle/fibrous with rounded chondrogenic morphology 2
Majority rounded/chondrogenic 3
MAXIMUM SCORE 9
Table 2. The Bern Score: Histological evaluation of engineered cartilage constructs.
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MA, USA) were used to evaluate the performance of 
constructs cultured with or without TGFβ1. Mice were 
placed under general anaesthesia using 2.5 % isoflurane. 
Two separate subcutaneous incisions of approximately 
10 mm were made along the central line of the spine (one 
at the shoulders and one at the hips), after which four 
separate subcutaneous pockets were prepared by blunt 
dissection of the subcutaneous tissue. For implantation, 
the alginate constructs were randomly assigned to these 
four pockets. Eight weeks after subcutaneous implantation, 
animals were sacrificed and samples were explanted for 
histological, biomechanical and biochemical analyses. 
Animal experiments were carried out with approval of 
the local Animal Experiments Committee of the Erasmus 
MC and were approved as outlined in the national Animals 
Act (EMC 2429).
Gene expression analyses
For total RNA isolation, alginate was dissolved in ice-
cold 55 mM sodium citrate (150 μL/bead) and 20 mM 
ethylenediaminetetraacetate (EDTA) in 150 mM NaCl and 
centrifuged at 2.5 g for 8 min. Each pellet was subsequently 
suspended in 1 mL RNA-Bee™ (Tel-Test, Friendswood, 
TX, USA). RNA was extracted with chloroform and 
purified from the supernatant using the RNAeasy 
Micro Kit (Qiagen, Hilden, Germany) according to the 
manufacturer’s guidelines by on-column DNA-digestion. 
Extracted total RNA was quantified using NanoDrop® 
ND-1000 Spectrophotometer (NanoDrop Technologies, 
Wilmington, DE, USA) at 260/280 nm. Total RNA of 
each sample was reverse transcribed into cDNA using 
RevertAid™ First Strand cDNA Synthesis Kit (MBI 
Fermentas, St. Leon-Rot, Germany).
 For quantitative real-time polymerase chain reaction 
(qRT-PCR) analysis, forward and reverse primers were 
designed using PrimerExpress 2.0 software (Applied 
Biosystems, Foster City, CA, USA) to meet TaqMan or 
SYBR Green requirements. They were designed to bind 
separate exons to avoid co-amplification of genomic DNA. 
Gene specificity of all primers was guaranteed by basic local 
alignment search tool (BLASTN), as listed in Table 1. The 
following genes were analysed: aggrecan (ACAN), collagen 
type IIA1 (COL2A1), collagen type X (COL10), alkaline 
phosphatase (ALP), and matrix metalloproteinase-13 
(MMP13). Glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH), and hypoxanthine phosphoribosyltransferase 1 
(HPRT1) were used as housekeeping genes. The expression 
of GAPDH and HPRT1 did not differ between cell sources 
and both were used to calculate the best housekeeper index 
(Pfaffl et al., 2004). Using repeated pair-wise correlation 
analysis, data were normalised by calculating the ‘best 
housekeeper index’ (data not shown). Polymerase chain 
reactions were performed using TaqMan® Universal PCR 
Mastermix (Applied Biosystems) or qPCR Mastermix Plus 
for SYBR Green (Eurogentec, Nederland BV, Maastricht, 
the Netherlands) according to the manufacturers’ guidelines 
and using an ABIPRISM® 7000 with SDS software version 
1.7 (Applied Biosystems, Nieuwerkerk a/d IJssel, the 
Netherlands). Amplification efficiencies for all assays were 
between 90-110 %. Relative gene expressions of triplicate 
samples of each donor were calculated by means of the 
2-ΔCT formula.
Biochemical evaluation of the extracellular matrix
Sample preparation
At room temperature, alginate beads and discs were 
dissolved in 55 mM sodium citrate and 20 mM EDTA in 
150 mM NaCl. All samples were then digested overnight at 
60 °C with papain buffer to a final concentration of 250 μg/
mL papain (0.2 M NaH2PO4, 0.01 M EDTA, pH 6.0, and 
freshly added 250 μg/mL papain and 5 mM L-cysteine), 
and later subjected to biochemical analyses to determine the 
DNA, glycosaminoglycan, and hydroxyproline contents.
DNA content
The amount of DNA measured in each papain-digested 
sample was determined by ethidium bromide (Gibco), 
using calf thymus DNA (Sigma-Aldrich) as a standard. 
Samples were analysed with a spectrofluorometer (Wallac 
1420 Victor 2; Perkin-Elmer, Wellesley, MA, USA), 
using an extinction filter (340 nm) and an emission filter 
(590 nm).
Glycosaminoglycan content
Sulphated glycosaminoglycans (GAGs) were quantified 
using the 1,9-dimethylmethylene blue (DMMB) dye-
binding assay. To be suitable for cell cultures containing 
alginate, the DMMB-pH-level was decreased to pH 1.75, 
as described previously (Enobakhare et al., 1996). The 
metachromatic reaction of DMMB was monitored using 
a spectrophotometer. Absorption ratios of 540 and 595 nm 
were used to determine the GAG content with chondroitin 
sulphate C (shark; Sigma-Aldrich) as a standard. For each 
sample, the amount of GAG was corrected for the amount 
of DNA.
Hydroxyproline content
The hydroxyproline content was quantified using a method 
described previously (Creemers et al., 1997). Briefly, the 
papain digests were hydrolysed with equal volumes of 12 M 
HCl at 108 °C for 18-20 h. Samples were then dried and re-
dissolved in 150 µL water. Hydroxyproline contents were 
measured using a colorimetric method (extinction, 570 nm), 
with chloramine-T and dimethylaminobenzaldehyde 
as reagents and hydroxyproline (Merck, Darmstadt, 
Germany) as a standard.
Histological evaluation of the extracellular matrix
After eight weeks of subcutaneous implantation, alginate 
discs were harvested, set in 2 % agarose, fixed in 4 % 
formalin in PBS and embedded in paraffin. Paraffin-
embedded sections (6 μm) were deparaffinised and 
rehydrated.
Immunohistochemistry for collagen type II, elastin and 
human vimentin
To allow the use of monoclonal mouse antibodies 
on constructs which have been implanted in athymic 
mice, we used a method to couple the first and second 
antibody before applying them on the sections to prevent 
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unwanted binding of the anti-mouse antibodies to mouse-
immunoglobulins (Hierck et al., 1994). In short, primary 
antibodies were pre-coupled overnight with goat anti-
mouse biotin at 4 °C (Jackson Laboratories, Bar Harbor, 
ME, USA), followed by a 2 h incubation in 0.1 % normal 
mouse serum (CLB, Amsterdam, the Netherlands) in order 
to capture the unbound second antibody.
 Antigen retrieval for the collagen type II antibody 
(Developmental Studies Hybridoma Bank, Iowa City, 
IA, USA) was performed through incubation with 0.1 % 
pronase (Sigma-Aldrich) in PBS for 30 min at 37 °C, 
continued with a 30 min incubation with 1 % hyaluronidase 
(Sigma-Aldrich) in PBS at 37 °C. Antigen retrieval for 
elastin (BA4, Sigma-Aldrich) required incubation with 
0.25 % trypsin (Sigma-Aldrich) in PBS for 20 min at 37 °C. 
Non-specific binding sites were blocked with 10 % goat 
serum (Sigma-Aldrich) in PBS and sections were stained 
with the pre-treated primary antibodies against collagen 
type II (1:100) or elastin (1:1000) for 60 min. Sections 
were than incubated with enzyme-streptavidin conjugate 
(Label, 1:100, Biogenex, HK-321-UK, San Ramon, CA, 
USA) in PBS, 1 % BSA, followed by incubation with Neu 
Fuchsin substrate (Chroma, Köngen, Germany). Positive 
staining for collagen II and elastin was confirmed with the 
use of native ear cartilage. A mouse monoclonal negative 
control antibody (mIgG1: X0931, Dako, Eindhoven, the 
Netherlands) was used as an isotype control.
 To study whether cells in the alginate constructs 
harvested after in vivo implantation were of human origin, 
a monoclonal mouse anti-human vimentin antibody was 
used (AMF-17b, Developmental Studies Hybridoma 
Bank), as described previously (Hellingman et al., 2011). 
In short, slides were incubated in 3 % aqueous hydrogen 
peroxidase solution, in order to inhibit endogenous 
peroxidase and allow for peroxidase-antiperoxidase 
staining. Antigen retrieval required incubation in Rodent 
Decloaker® for 60 min at 95 °C. Non-specific binding sites 
were blocked with Rodent Block M® followed by a 30 min 
staining with vimentin (1:40, V6630, Sigma-Aldrich). 
Thereafter, the MM-polymer-HRP® secondary antibody 
was used, followed by incubation with 3’diaminobenzidine 
chromogen solution (Sigma-Aldrich). Tissue specificity 
was confirmed by the absence of staining on sections of 
mouse liver tissue. A mouse monoclonal negative control 
antibody was used as an isotype control.
Von Kossa/Thionin/Resorcin-Fuchsin staining
To evaluate tissue calcification, a Von Kossa staining was 
performed. Slides were immersed in 5 % silver nitrate 
solution (Sigma-Aldrich) for 10 min, rinsed in MiliQ water 
and exposed to light for another 10 min. Sections were 
counterstained with Nuclear fast red (Merck, Rayway, 
NJ, USA).
 GAGs were visualised using 0.4 % Thionin (Sigma-
Aldrich) in 0.01 M aqueous sodium acetate (pH 4.5) for 
5 min at room temperature. To check whether we stained 
GAGs rather than the remaining alginate, sections were 
pre-treated with 20 mM EDTA (Sigma-Aldrich). As EDTA 
treatment did not change the intensity and/or localisation 
of thionin on our slides, we confirmed that alginate did not 
interfere with our GAG-staining protocol. The presence, as 
well as the arrangement of the elastic fibres, was visualised 
using Weigert’s Resorcin-Fuchsin staining (Klinipath, 
Duiven, the Netherlands).
 We used a semi-quantitative scoring system – The Bern 
Score (Grogan et al., 2006) – to evaluate the chondrogenic 
capacity of alginate-encapsulated cells after subcutaneous 
implantation (Table 2). In short, the scoring system 
evaluates cartilage formation based on three elements: 
(1) the uniformity and/or intensity of the thionin and 
collagen type II staining; (2) the distance between cells 
and the extent of matrix produced; and (3) the cellular 
morphology. Each category has scores ranging from 0 to 
3, resulting in a possible minimum collective score of 0 
and a maximum of 9. Samples that were either not visible 
anymore after eight weeks of subcutaneous implantation 
or were dissolved during formalin fixation were scored 0.
Biomechanical analysis
For mechanical characterisation of engineered cartilage 
constructs after in vitro and in vivo cell culture, we 
used 2.5 mm thick and 5 mm diameter constructs. The 
samples were placed in a close-fitting Ø5 mm stainless 
steel cylindrical wells. Mechanical testing was performed 
with a materials testing machine (Zwick Z005, Ulm, 
Germany) equipped with a 10 N load cell, a built-in 
displacement control, and a cylindrical, plane-ended, 
stainless steel indenter (Ø1.2 mm). During mechanical 
testing the samples were immersed in PBS. Stress-strain 
testing was performed: the samples were compressed to a 
final height of 0.5 mm at a loading rate of 5 mm per min. 
An in-house Matlab® script was used to locate the sample 
surface and measure the sample thickness. The sample 
surface was identified by detecting the corresponding 
slope discontinuity of the force-displacement curve using 
its second derivative. Force-displacement curves were then 
converted to stress-strain curves. Compressive modulus 
at 40 % strain (E40 %), defined as the derivative of the 
stress-strain curve at 40 % strain, was determined for every 
sample (n = 98).
Statistical analysis
All data were analysed with PASW Statistics 20.0 (SPSS 
inc. Chicago, IL, USA). The mean and standard deviations 
are presented. For statistical evaluation, a mixed linear 
model was used. Cell source, time point and treatment 
(TGFβ1) were defined as fixed factors in the model. Donor 
and sample number were treated as random factors. Values 
of p < 0.05 were considered statistically significant. For 
histological scoring we used the Kruskal-Wallis followed 
by the Mann-Whitney U tests for their statistical analysis 
(p < 0.05). In order to determine whether mechanical 
properties were enhanced by the deposition of matrix 
components, a multiple regression analyses was performed 
using GAG and collagen deposition as independent 
variables (p < 0.05).
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Results
Cell expansion
The cell sources showed clear differences in growth 
rate. NCs proliferated significantly faster than ECs, ACs 
and aMSCs (p < 0.05). NCs had gone through 8.9 ± 1.7 
population doublings (PD) in four passages taking 28 ± 5 d, 
ECs had gone through 6.8 ± 1.3 PD in 38 ± 6 d and ACs 
through 3.9 ± 1.1 PD in 44 ± 13 d. It took 39 ± 8 d for 
bMSCs and 48 ± 8 d for aMSCs to complete 4 passages 
(Table 3).
Chondrogenic differentiation in vitro
After cell-expansion, cells were encapsulated in clinical-
grade alginate to promote chondrogenesis. Alginate beads 
cultured without TGFβ1 had maintained their DNA content 
after 5 weeks of culture. Addition of TGFβ1 significantly 
increased the total amount of DNA in alginate beads seeded 
with ECs and NCs (p < 0.001), which was also significantly 
higher compared to the other cell sources (p < 0.05), 
indicating that those cells were able to proliferate after 
encapsulation in alginate. The other cell conditions 
remained at a stable cell content (Fig. 1A).
 Chondrocytes did express low levels of COL2A1 and 
ACAN without TGFβ1. After chondrogenic induction (with 
TGFβ1), the COL2A1 and ACAN gene expression levels 
increased in all cell sources used. Both genes were most 
highly expressed by ACs (p < 0.001), followed by bMSCs 
(Fig. 1B). This was already seen after 2 weeks of culture 
(data not shown), suggesting that chondrogenesis was not 
only enhanced but also accelerated.
 Matrix production was quantified by GAG and collagen 
content of alginate beads during in vitro culture. Without 
TGFβ1 very little GAG was formed in vitro. Addition of 
TGFβ1 enhanced GAG production and after 5 weeks of 
culture ACs deposited significantly more GAGs (p < 0.01). 
When GAG content was adjusted to the amount of DNA, 
similar but more pronounced differences were observed 
(ACs produced most GAGs: 60.89 ± 53.04 μg GAG / 
μg DNA; p < 0.001). GAG content per alginate bead 
in constructs containing bMSCs, ECs, NCs and aMSCs 
was not significantly different, although a large donor 
variation was observed. Also with large variation between 
donors, aMSCs performed worse. The amount of collagen 
deposited was just above background for all cell sources 
after 5 weeks of chondrogenic differentiation, being on 
average 1.53 ± 1.84 μg collagen per alginate bead (Fig. 
1C).
Chondrogenic differentiation in vivo
To study the stability and quality of TE cartilage in vivo, 
alginate constructs were first differentiated in vitro for 
5 weeks and subsequently implanted subcutaneously 
on the dorsal side of athymic mice for an additional 8 
weeks of culture. Constructs seeded with ECs or NCs, 
pre-cultured with TGFβ1, had a macroscopically white 
opaque appearance and were relatively strong on handling. 
Conversely, constructs pre-cultured without TGFβ1 or 
constructs encapsulating ACs, bMSCs or aMSCs, were 
fragile and also did not resemble cartilaginous tissue 
macroscopically (Figs. 2A and 3A).
 Prior to implantation, constructs pre-cultured without 
TGFβ1 produced very little GAG in vitro, being on 
average 1.10 ± 1.20 µg GAG per construct. After in 
vivo implantation, these constructs greatly increased 
their production of matrix components, although they 
did not reach levels which equalled the matrix content 
found in constructs cultured with TGFβ1 (Fig. 2B). After 
subcutaneous implantation preceded by chondrogenic 
culture (with TGFβ1), ACs, bMSCs and aMSCs retained 
their GAG content but did not further increase it. In contrast, 
ECs and NCs significantly enhanced matrix formation in 
vivo (EC 7.26-fold and NC 2.86-fold ; both p < 0.001) 
leading to a superior GAG deposition after implantation 
compared to the other cell sources (both p < 0.001). These 
results were further confirmed by Thionin-staining (data 
not shown). Total collagen deposition was hugely increased 
after implantation and no significant differences could be 
detected between the different cell sources (Fig. 3B).
 Constructs containing ACs, bMSCs or aMSCs exhibited 
a very weak staining for cartilage-specific collagen type II 
(Fig. 3C), which was in contrast to the overall production 
of collagens (Fig. 3B), thus indicating that other collagens 
were also produced (e.g. collagen type I or type III). The 
cartilage matrix of constructs containing ECs and NCs 
showed a strong staining for collagen type II, although 
PD/D Statistically significantly different from
EC 0.18 ± 0.04 NC (p = 0.015) ; AC (p = 0.008)
NC 0.32 ± 0.07 EC (p = 0.015) ; AC (p < 0.001) ; aMSC (p = 0.013)
AC 0.10 ± 0.05 EC (p = 0.008) ; NC (p < 0.001) ; bMSC (p = 0.001)
bMSC 0.25 ± 0.09 AC (p = 0.001)
aMSC 0.16 ± 0.04 NC (p = 0.013)
Table 3. Population doubling time of different cell types over four passages.
NCs proliferated faster than ECs, ACs and aMSCs. The proliferation rate of 
bMSCs did not differ from aMSCs. Data are shown as mean ± SD. PD/D = 
population doublings per day (PD/D = (ln(N2/N1)/ln (2))/D); EC = ear 
chondrocytes (n = 3 donors); NC = nasal chondrocytes (n = 3 donors); 
AC = articular chondrocytes (n = 3 donors); bMSC = bone marrow-derived 
mesenchymal stem cells (n = 3 donors); aMSC = adipose tissue-derived 
mesenchymal stem cells (n = 3 donors).
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Fig. 1. Cartilage matrix formation by several cell types in vitro. To promote chondrogenesis, cells were encapsulated 
in alginate beads and cultured without (dotted) or with (black) TGFβ1 for 5 weeks. (A) Cell content. DNA content was 
determined before culture (dotted line), being on average 0.53 ± 0.183 μg DNA per alginate bead, and after 5 weeks 
of culture. The amount of DNA was significantly higher in constructs containing ECs or NCs. (B) Gene-expression 
analyses. Relative gene expression levels of COL2A1 and ACAN were corrected for the best housekeeper index. All cell 
sources expressed ACAN and COL2A1 after chondrogenic induction. (C) Biochemical analyses. Biochemical evaluation 
of the glycosaminoglycan (GAG) and collagen content after chondrogenic induction in alginate beads. ACs deposited 
most GAGs. Collagen production was low in vitro. Data are shown as mean ± SD. For statistical evaluation, a mixed 
model was used. *, ** or *** indicates p-values less than 0.05, 0.01 or 0.001, respectively, compared to the control 
condition (asterisk is shown in the bar) or compared to the other cell sources (asterisk is shown above the bar). EC = 
ear chondrocytes (n = 4 donors); NC = nasal chondrocytes (n = 4 donors); AC = articular chondrocytes (n = 4 donors); 
bMSC = bone marrow-derived mesenchymal stem cells (n = 6 donors); aMSC = adipose tissue-derived mesenchymal 
stem cells (n = 6 donors). Per donor, 2-3 samples were used for analyses.
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dissimilar distributions of collagen type-II fibres within 
the cartilage matrices were apparent. The semi-quantitative 
histological scores of constructs containing ECs or NCs 
were significantly better than the scores of the other cell 
sources (Fig. 3C).
 The presence of elastin was determined to evaluate 
differentiation into elastic cartilage. There was no 
elastin detectable in any of the constructs with an elastin 
immunostaining after 5 weeks of in vitro cell culture (data 
not shown). After subcutaneous implantation, elastin was 
only present in alginate constructs containing ECs, and 
predominantly found in constructs which were pre-cultured 
with TGFβ1. Most elastin was located around the cell (Fig. 
3D).
 To ensure that these cartilage constructs were of 
human origin, a human-specific vimentin stain was used 
on histological sections. It confirmed that the cartilage 
constructs were indeed of human origin (Fig. 3E), while 
the surrounding fibrous tissue was not (data not shown).
Cartilage stability
Hypertrophic differentiation is an unwanted phenomenon 
in cartilage regeneration, resulting in cartilage that can 
remodel into bone when implanted in vivo. To evaluate 
hypertrophy in vitro, we have studied gene expression 
of a panel of three hypertrophic markers during 5 weeks 
of cell culture (i.e. COL10, ALP and MMP13; Fig. 4A). 
Cultured with TGFβ1, COL10 expression was highest in 
NCs (p < 0.05) and bMSCs (p < 0.001), and was minimally 
expressed by ACs. MMP13 was expressed by all cells 
and significantly highest in NCs. ALP was significantly 
higher in constructs with bMSCs compared to the other 
cell sources (p < 0.05). In addition, constructs with bMSCs 
already expressed high COL10 and ALP after 2 weeks of 
culture, indicating early hypertrophic differentiation (data 
not shown).
 Although bMSCs expressed all hypertrophic markers 
in vitro, they did not mineralise or form bone after 8 weeks 
of subcutaneous implantation. Also, no signs of tissue 
calcification or bone formation were observed in constructs 
containing aMSCs. In contrast, 100 % (3/3) of the cell-free 
constructs and, unexpectedly, 58.3 % (7/12) of constructs 
encapsulating ACs did calcify in vivo. Also, calcification 
was more often seen in constructs pre-cultured in control 
medium (without TGFβ1) compared to constructs cultured 
in chondrogenic medium (with TGFβ1) (Fig. 4B).
Fig. 2. Cartilage matrix formation by several cell types in vivo. Prior to subcutaneous implantation, constructs were 
cultured in vitro for 5 weeks in the absence of TGFβ1. (A) Macroscopic view of engineered cartilage constructs after 
8 weeks of subcutaneous implantation. (B) Biochemical analyses. Biochemical evaluation of the glycosaminoglycan 
(GAG) and collagen content after subcutaneous implantation on the dorsal side of athymic mice. ECs and NCs 
deposited most GAGs in vivo. Collagen production was increased in vivo, but did not differ between the cell sources. 
The grey bars represent the in vivo biochemical data of constructs cultured in vitro for 5 weeks in the presence of 
TGFβ1 (Fig. 3). (C) Immunohistochemical analyses of collagen type II. ECs and NCs demonstrated a collagen type 
II-rich matrix in almost all cartilage constructs. Biochemical data are shown as mean ± SD. For statistical evaluation, 
a mixed model was used. *, ** or *** indicates p-value less than 0.05, 0.01 or 0.001, respectively, compared to the 
other cell sources. EC = ear chondrocytes (n = 3 donors); NC = nasal chondrocytes (n = 3 donors); AC = articular 
chondrocytes (n = 3 donors); bMSC = bone marrow-derived mesenchymal stem cells (n = 3 donors); aMSC = adipose 
tissue-derived mesenchymal stem cells (n = 3 donors). Per donor, 2 samples were used for analyses.
272 www.ecmjournal.org
MM Pleumeekers et al.                                                                Comparison of cell sources for cartilage regeneration
Fig. 3. Cartilage matrix formation by several cell types in vivo. Prior to subcutaneous implantation, constructs were 
cultured in vitro for 5 weeks in the presence of TGFβ1. (A) Macroscopic view of engineered cartilage constructs after 8 
weeks of subcutaneous implantation. (B) Biochemical analyses. Biochemical evaluation of the glycosaminoglycan (GAG) 
and collagen content after subcutaneous implantation on the dorsal side of athymic mice. ECs and NCs deposited most 
GAGs in vivo. Collagen production was increased in vivo, but did not differ between the cell sources. (C) Collagen type 
II. ECs and NCs demonstrated a collagen type II-rich matrix in almost all cartilage constructs, leading to significantly 
better semi-quantitative Bern’s scores than the other cell sources. (D) Elastin. Elastin was not formed in vitro. After 
subcutaneous implantation, only constructs containing ECs were able to produce elastin. Most elastin fibres were 
found around the cell. Elastin = Immunohistochemical staining for elastin; RF = Resorchin Fuchsin, chemical staining 
for elastin. (E) Human vimentin. All cartilage constructs were of human origin. Biochemical data are shown as mean 
± SD. For statistical evaluation, a mixed model was used. Histological data are shown as the median of individual data 
points. For statistical evaluation, a Kruskal-Wallis test was used followed by Mann-Whitney-U comparison. *, ** or *** 
indicates p-values less than 0.05, 0.01 or 0.001, respectively, compared to the other cell sources. EC = ear chondrocytes 
(n = 3 donors); NC = nasal chondrocytes (n = 3 donors); AC = articular chondrocytes (n = 3 donors); bMSC = bone 
marrow-derived mesenchymal stem cells (n = 3 donors); aMSC = adipose tissue-derived mesenchymal stem cells (n = 3 
donors). Per donor, 2 samples were used for analyses.
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Fig. 4. Stability of cartilage constructs in vitro and in vivo. (A) Hypertrophy in vitro. Relative gene expression levels 
of COL10, ALP and MMP13 were examined after 5 weeks of culture and corrected for the best housekeeper index. 
Hypertrophic genes were most highly expressed by bMSCs and NCs. Data are shown as mean ± SD. For statistical 
evaluation, a mixed model was used. *, ** or *** indicates p-values less than 0.05, 0.01 or 0.001, respectively, 
compared to the control condition (asterisk is shown in the bar) or compared to the other cell sources (asterisk is 
shown above the bar). EC, NC and AC: n = 4 donors each; bMSC, aMSC: n = 6 donors each. (B) Mineralisation 
in vivo. Von Kossa staining was used to evaluate construct calcification in vivo. MSCs did not calcify the construct 
in vivo. Non-seeded alginate and constructs encapsulating ACs did calcify. For each cell source we had a total of 6 
alginate constructs: duplicate samples of 3 different donors. EC = ear chondrocytes; NC = nasal chondrocytes; AC = 
articular chondrocytes; bMSC = bone marrow-derived mesenchymal stem cells; aMSC = adipose tissue-derived 
mesenchymal stem cells.
Fig. 5. Biomechanical evaluation of constructs with different cell types. Biomechanical properties enhanced after in 
vivo implantation. ECs and NCs tended to exhibit superior mechanical properties in vivo compared to the other cell 
sources. Since tissue calcification misrepresents the biomechanical properties of the cartilage matrix; we excluded 
calcified cartilage constructs for further analyses (grey bar represents the mechanical properties of both calcified 
and non-calcified constructs). Biomechanical data are shown as mean ± SD. EC = ear chondrocytes (n = 3 donors); 
NC = nasal chondrocytes (n = 3 donors); AC = articular chondrocytes (n = 3 donors); bMSC = bone marrow-derived 
mesenchymal stem cells (n = 3 donors); aMSC = adipose tissue-derived mesenchymal stem cells (n = 3 donors). Per 
donor, 2 samples were used for analyses.
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Cartilage structure and functionality
The elastic modulus of constructs was low in vitro, 
irrespective of the cell source used, being on average 
7.42 ± 2.10 kPa. However, after subcutaneous implantation, 
mechanical properties improved in constructs containing 
either ECs (23.68 ± 10.20) or NCs (55.12 ± 59.25), but 
was not perceived in constructs containing ACs, bMSCs 
or aMSCs (Fig. 5). Since tissue calcification misrepresents 
the biomechanical properties of the cartilage matrix; 
we excluded calcified cartilage constructs from further 
analyses.
 To determine whether the mechanical properties were 
enhanced by the deposition of matrix components, a 
multiple regression analyses was performed for all cell 
sources separately using GAG and collagen deposition 
as independent variables. Only for constructs containing 
NCs, matrix components significantly associated with the 
biomechanical functionality of the constructs (R2 = 0.477, 
F = 4.558, p = 0.039). For these constructs, only GAG 
deposition associated significantly with the biomechanical 
properties of the cartilage constructs independently (GAG: 
β = 0.689, p = 0.013; collagen: β = 0.044, p = 0.851).
Discussion
For successful regeneration of cartilage tissue, selection 
of the most appropriate cell source is crucial. This 
study demonstrates that cartilage matrix formation 
and functionality is cell source dependent; articular 
chondrocytes (ACs) possess the highest chondrogenic 
capacity in vitro, while ear chondrocytes (ECs) and 
nasal chondrocytes (NCs) are most potent for cartilage 
regeneration after subcutaneous implantation in vivo.
 To date, we and others have evaluated the use of 
chondrocytes and mesenchymal stem cells (MSCs) 
from several anatomical locations for their applicability 
in cartilage regenerative medicine (Afizah et al., 2007; 
Asawa et al., 2009; Chung et al., 2008; Hellingman et al., 
2011; Henderson et al., 2007; Isogai et al., 2006; Johnson 
et al., 2004; Kafienah et al., 2002; Karlsson et al., 2007; 
Kusuhara et al., 2009; Lohan et al., 2011; Malicev et 
al., 2009; Naumann et al., 2004; Panossian et al., 2001; 
Sakaguchi et al., 2005; Seda Tigli et al., 2009; Tay et al., 
2004; van Osch et al., 2004; Vinardell et al., 2012; Xu 
et al., 2004; Yoshimura et al., 2007; Zhang and Spector, 
2009). However, these studies often used non-expanded 
cells isolated from animals. Moreover, a detailed direct 
comparison between various chondrocyte and MSC- 
sources was lacking. Therefore, this study is the first to 
systematically compare the quality and tissue stability 
of engineered cartilage constructs produced by culture-
expanded ACs, NCs, ECs, bMSCs and aMSCs of human 
origin.
 We have used culture-expanded human cells, to closely 
simulate the clinical situation. For clinical application, the 
use of autogeneic cells is favourable, since these cells do 
not elicit a tissue rejection response. However, it has been 
difficult to obtain appropriate numbers of cells, as donor 
tissue is limited and harvesting can cause large donor 
site morbidity. Consequently, monolayer cell expansion 
has become an essential step in the process of cartilage 
TE. To fulfil this requirement, we culture-expanded all 
cells for four passages. It was obvious that different cells 
went through a different number of population doublings 
during these four passages; ACs had gone through the least 
number of population doublings confirming earlier findings 
of slow proliferation of ACs (Henderson et al., 2007; Isogai 
et al., 2006; Kafienah et al., 2002; van Osch et al., 2004).
 To be able to use expanded cells for the reconstruction 
of cartilage defects, cells should be stimulated to regain 
their cartilage-matrix-forming capacity. Several research 
groups have shown that expanded cells can regain their 
chondrogenic potential under specific culture conditions: 
(1) the use of a 3D-culture system, and/or (2) the 
administration of chondrogenic factors, such as TGFβ 
(Yaeger et al., 1997). In order to generate a 3D-culture 
environment, we have encapsulated all cells in clinical 
grade alginate, since alginate enables a homogeneous 
cell distribution, prevents cells from floating out while 
permitting nutrient diffusion and oxygen transfer to the 
encapsulated cells, and promotes the synthesis of cartilage-
specific matrix components, such as GAGs and collagen 
type II (Hauselmann et al., 1992). Surprisingly, we showed 
that alginate appears to have the tendency to calcify in vivo, 
since 20 % of all constructs calcified during subcutaneous 
implantation. Especially, cell-free constructs and constructs 
encapsulating ACs suffered from this phenomenon. Also, 
calcification was more often seen in constructs pre-
cultured in medium without TGFβ1. To our knowledge, 
calcium-cross-linked alginate calcifies through binding the 
surrounding phosphate ions to form calcium phosphate 
crystals. These crystals are stable in neutral to basic 
environments and do not appear at pH of less than 6.8 (Lee 
et al., 2010). We believe that the calcified constructs were 
possibly generated in a neutral to alkaline environment 
prior to implantation, since these constructs were either 
not metabolically active (non-seeded alginate) or had a low 
metabolic activity due to stable cartilage formation (ACs) 
or due to the deficiency of TGFβ1. Obviously, in these 
constructs, calcification did not seem to be a consequence 
of instable cartilage formation, but was more likely a 
typical characteristic of alginate itself. Surprisingly and 
in contrast to our previous work with MSCs in collagen 
scaffolds (Farrell et al., 2009) or in pellets without 
scaffold (Hellingman et al., 2012), constructs containing 
MSCs (both bMSCs and aMSCs) never mineralised 
in vivo, although signs of endochondral differentiation 
were observed prior to implantation. The absence of 
endochondral ossification during in vivo implantation 
was accompanied by lack of neovascularisation or vessel 
ingrowth within the matrix, which is known to be extremely 
important for endochondral ossification (Kanczler and 
Oreffo, 2008). We believe that alginate prevented this 
process, by the fact that endothelial cells lack receptors to 
bind to alginate polymers, prohibiting neovascularisation 
or vessel ingrowth (Alsberg et al., 2001). Therefore, it 
seemed that alginate could be an excellent cell-carrying 
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gel for cartilage regeneration, although future work needs 
to clarify which approach is required to exclude alginate 
calcification after in vivo implantation.
 In addition to a 3D-culture environment, specific 
growth and differentiation factors will help to regain and 
induce a chondrocyte-like phenotype. In vitro, culture-
expanded cells of all sources studied failed to differentiate 
towards the chondrogenic lineage in the absence of TGFβ1, 
as assessed by an almost negligible deposition of GAGs 
and the inferior expression of both ACAN and COL2A1 
in alginate constructs. The presence of TGFβ1 induced 
chondrogenic differentiation in vitro, where ACs exhibit 
a superior chondrogenic capacity in vitro, compared to 
the other cell sources. The beneficial effect of culturing 
with TGFβ1 during in vivo chondrogenesis was present, 
although less obvious. Constructs cultured without TGFβ1 
increased their production of matrix components after in 
vivo implantation, but were not able to reach levels found 
in constructs cultured with TGFβ1.
 Even after four passages of culture expansion, 
chondrocytes demonstrated some clear subtype specific 
differences. Firstly, ACs possessed the highest chondrogenic 
capacity in vitro, but were not able to further increase their 
cartilage matrix in vivo. The inability of ACs to promote 
cartilage formation in vivo may be due to the lack of 
mechanical loading or growth factor stimulation after 
subcutaneous implantation, which may have led to a loss 
of chondrogenic capacity. ACs, different from the other 
cell sources, are exposed to mechanical loading within 
native articular cartilage and unloading is known to induce 
GAG-release from the cartilage matrix and to reduce cell 
proliferation and GAG synthesis within the matrix (Tomiya 
et al., 2009). Secondly, chondrocytes from ear cartilage 
were able to form an elastin network after subcutaneous 
implantation in vivo. Elastin was predominantly found 
in constructs which were cultured with TGFβ1. In vitro 
culture did not demonstrate elastin deposition at all, which 
was in accordance with our previous work (Hellingman 
et al., 2011). The capability of culture-expanded ECs to 
produce elastin in vivo suggests that these cells retain their 
capability to form an elastic cartilage matrix. Both findings 
– the inability of ACs to promote cartilage formation in 
vivo without mechanical loading and the ability of cultured 
expanded ECs to produce elastin – indicate that both cell 
types preserved their subtype specific phenotype after 
culture expansion, confirming our previous study where 
gene expression profiles of culture-expanded NCs and 
ECs displayed clear differences that were related to their 
developmental origin (Hellingman et al., 2011).
 Besides chondrocytes, MSCs have been demonstrated 
to be an attractive cell source for cartilage TE (Barry et 
al., 2001; Caplan, 1991; Johnstone et al., 1998; Pittenger 
et al., 1999). Although bone marrow offers the most 
common source of MSCs, adipose tissue has been proven 
to be an attractive alternative in respect to the abundant 
and easily accessible pool of MSCs (Zuk et al., 2002; Zuk 
et al., 2001). We have demonstrated that both bMSCs and 
aMSCs underwent chondrogenic differentiation in vitro 
and in vivo, although matrix production was less than in 
constructs containing chondrocytes (ACs, NCs or ECs). 
Constructs containing bMSCs had a higher chondrogenic 
potential than aMSCs, demonstrated by an increased 
ACAN and COL2A1 gene-expression and an improved 
GAG deposition. With the exception of a few studies (De 
Ugarte et al., 2003; Izadpanah et al., 2006; Kern et al., 
2006; Lee et al., 2004), this confirms other studies (Afizah 
et al., 2007; Huang et al., 2005; Im et al., 2005; Liu et al., 
2007; Mehlhorn et al., 2006; Noel et al., 2008; Rebelatto 
et al., 2008; Rider et al., 2008; Sakaguchi et al., 2005; 
Segawa et al., 2009; Winter et al., 2003). Nevertheless, 
the assumptions that MSCs are fundamentally less 
chondrogenic than chondrocytes, and that bMSCs are 
more in favour for cartilage regeneration than aMSCs, 
seems unjustified. It appears that cell culture conditions 
for both bMSCs and aMSCs remain to be improved. For 
instance, it was found that another member of the TGFβ-
superfamily, bone morphogenetic protein 6, is obligatory 
to improve chondrogenic differentiation in aMSCs (Estes 
et al., 2010).
 Finally, in order to understand how the distribution 
and composition of matrix components resulted 
in a mechanically functional cartilage matrix, the 
compositional-biomechanical relationship of the cartilage 
constructs was evaluated. After in vivo implantation, 
mechanical properties increased in constructs containing 
ECs and NCs. Only for constructs containing NCs, 
matrix components were significantly correlated to their 
biomechanical functionality. It is already known that GAGs 
and collagens, the main components of the ECM, are both 
associated with the biomechanical properties of native 
cartilage: (1) the negatively charged GAGs provide an 
osmotic pressure within the tissue; and (2) the architecture 
of the collagen network captures the GAGs and prevents 
them from leaking out of the tissue (Han et al., 2011). In 
contrast, the elastic fibre network in constructs containing 
ECs might have influenced the biomechanical properties 
in vivo as well, although the exact contribution of elastin 
to mechanical functionality is not yet fully understood. 
Besides the existence of matrix components, the quality 
of the matrix is not only determined by the amount of 
matrix components deposited, but also influenced by the 
number of cross-links between matrix molecules (i.e. 
collagen cross-links) (Bastiaansen-Jenniskens et al., 
2008a). The distribution of matrix components in the 
ECM was clearly different between cell sources: ECs 
deposited most matrix components pericellularly, whereas 
NCs deposited these matrix components homogenously 
throughout their matrix, which was clearly visible on the 
immunohistochemical collagen type II staining. It is well 
known that a heterogeneously distributed matrix alters the 
biomechanical properties of the matrix, as the physical 
properties are determined by the weakest point in the matrix 
(Mow and Guo, 2002).
 The present study has certain limitations. Firstly, cell 
density plays a critical role in functional and stable cartilage 
formation. Others have demonstrated that cell densities 
greater than 20 x 106 cells per mL are desirable, while low 
cell densities resulted in decreased cartilage formation 
(Puelacher et al., 1994). Therefore, a potential drawback 
of our study is that we only could use a cell-seeding 
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density of 4 x 106 cells per mL of alginate, since the size 
of our experimental set-up did not enable higher densities. 
Secondly, as mentioned before, we have culture-expanded 
all cells until passage four to obtain a sufficient number 
of cells. In order to be able to compare all different cell 
sources, we have used standardised protocols for the culture 
expansion of both chondrocytes and MSCs. Differences in 
expansion rates between the different cells were obvious. 
While culture expansion is associated with chondrocyte 
dedifferentiation and replicative cell senescence, the 
enforcement of population doublings instead of culture 
passages might have been more appropriate, since 
population doublings more accurately reflect cell growth 
and thus cell aging. However, since nasal chondrocytes had 
most doublings in four passages but still produced most 
cartilage, a direct link between doublings and cartilage 
formation seems unlikely. How all the parameters such 
as number of doublings, expansion speed, initial seeding 
density, growth factors present in the medium or produced 
by the cells themselves exactly determine dedifferentiation 
and possible loss of chondrogenic capacity during 
monolayer expansion remains to be elucidated. Finally, 
we have demonstrated large donor variation in constructs 
containing ACs or bMSCs. Nevertheless these differences 
were not based on a donor-age effect nor explained 
by the use of healthy versus diseased ACs. Moreover, 
donors for nasal cartilage appeared younger than other 
sources. Although there is a possibility that the donor 
age has influenced the general outcome of our study, 
improved chondrogenic and proliferative capacity of nasal 
chondrocytes was also stated by others in the literature 
(Kafienah et al., 2002; Naumann et al., 2004; Tay et al., 
2004).
 In summary, we have demonstrated that cartilage matrix 
formation and functionality are cell source dependent. 
Articular chondrocytes possess the highest chondrogenic 
capacity in vitro, while ear and nasal chondrocytes are 
most potent for cartilage regeneration after subcutaneous 
implantation, making ear and nasal chondrocytes attractive 
cell sources for future cell-based cartilage repair. Only 
for constructs containing nasal chondrocytes, GAG and 
collagen content were associated with biomechanical 
functionality of the constructs, indicating the differences 
in matrix component assembly by different cell sources. 
The inability of articular chondrocytes to increase cartilage 
matrix in vivo may be due to a loss of chondrogenic 
capacity in the absence of mechanical loading or growth 
factor stimulation. Although mesenchymal stem cells are 
considered as a promising cell source for the reconstruction 
of cartilage defects, it appears that improvements in cell 
culture conditions for both bone-marrow-derived and 
adipose tissue-derived mesenchymal stem cells are needed.
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Discussion with Reviewers
Reviewer I: The authors imply that alginate might be a 
good carrier because encapsulated MSCs show diminished 
hypertrophy. However, could the mechanical properties 
of a cell/alginate hybrid ever be strong enough and if the 
alginate were gone, would the stabilising effect be lost?
Authors: We would like to emphasise that alginate did 
not seem to inhibit hypertrophic differentiation of bMSCs 
in vitro (alginate constructs containing bMSCs highly 
expressed hypertrophic markers such as COL10 and ALP 
after 2 and 5 weeks of in vitro culture). In our opinion, 
alginate prevented vascular ingrowth, which resulted in 
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the absence of bone formation 8 weeks after subcutaneous 
implantation.
 We agree with the reviewer that the biomechanical 
properties of the alginate used were low and inferior 
to that of native cartilages (e.g. ear cartilage: Eeq 
3.3 ± 1.3 MPa (Nimeskern et al., 2013); articular cartilage: 
Eeq 10.9 ± 5.0 MPa (Richard et al., 2013)). However, 
alginate was chosen since it is being used as a cell carrier 
for clinical applications in cell-based cartilage repair 
(Almqvist et al., 2009; Selmi et al., 2008). Injected 
into a mechanically stable scaffold, alginate enables a 
homogeneous cell distribution into a mechanically stable 
environment. Moreover, it prevents cells from floating out 
while permitting nutrient diffusion and oxygen transfer to 
the encapsulated cells and thereby promotes the synthesis 
of cartilage-specific matrix components, such as GAGs and 
collagen type II (Hauselmann et al., 1992). Therefore, in 
our opinion, alginate injected into a mechanically stable 
scaffold could be an excellent therapy for cell-based 
cartilage repair. By the time alginate is completely gone 
(which will depend on the type of alginate and can take 
months), we hope the cartilage formed is mature and stable 
and will not undergo endochondral ossification anymore. 
However, this remains to be evaluated with long term in 
vivo experiments.
Reviewer I: What does it mean when large areas are 
negative for vimentin in Fig. 3E? Are some of the cells of 
host origin or is vimentin expression very variable?
Authors: Vimentins are class-III intermediate filaments 
and primarily expressed in cells of mesenchymal origin. 
Vimentins are attached to the nucleus, endoplasmic 
reticulum, and mitochondria. Strong positivity for the 
vimentin antibody is therefore demonstrated by a brown 
staining of the cell nucleus and cytoplasm. In our positive 
control of human cartilage, all cells were positive. The 
large area negative for vimentin is in our opinion the 
extracellular matrix, but we agree with the reviewer that 
some background stain was visible.
Reviewer I: The influence of alginate on construct 
‘ossification’ should be questioned.
Authors: We have demonstrated that cell-free alginate 
constructs did mineralise in vivo, which was an unexpected 
finding and obviously not related to hypertrophic 
differentiation. It seemed that less metabolically active 
(meaning the colour of the culture medium was neutral 
to alkaline) alginate constructs were likely to mineralise 
in vivo. This is obviously a typical characteristic of 
alginate itself and it very valuable to know since 
alginate is actually being used in (experimental) clinical 
applications. Furthermore, cell-alginate constructs 
expressing hypertrophic genes in vitro, never calcified nor 
formed bone in vivo. This is a very promising outcome 
and indicates a possible benefit for the use of alginate as 
a cell-carrier for cartilage reconstruction.
Reviewer II: Unlike previous studies from the authors 
using MSCs seeded onto collagen scaffolds or in pellets, 
MSC-alginate constructs did not undergo endochondral 
ossification in vivo. Can the authors speculate as to why 
they believe this to be the case?
Authors: In our opinion, endochondral ossification 
requires 1) proper chondrogenic differentiation, 2) 
hypertrophic differentiation, and 3) a matrix that allows 
vessel ingrowth. We demonstrated that after chondrogenic 
induction (with TGFβ1), alginate constructs containing 
bone marrow-derived MSCs (bMSCs) chondrogenically 
differentiated and expressed hypertrophic markers in vitro, 
but did not form bone after subcutaneous implantation. 
Therefore, we believe that alginate did not necessarily 
inhibit hypertrophic differentiation of bMSCs, but 
prevented vessel ingrowth and subsequent bone formation.
 Vessel ingrowth is extremely important for endochondral 
ossification. Angiogenesis in alginate is unlikely since 
vessels are unable to invade it. Although, alginate and other 
hydrogels have been used for research on bone regeneration 
(Park, 2011), modification of hydrogels with bioactive 
molecules (e.g. RGDs) seemed important allowing cell 
attachment and thereby vessel ingrowth.
 To conclude, we believe that alginate differs from 
pellets or collagen scaffolds by preventing vascular 
ingrowth, thus resulting in the absence of bone formation 
8 weeks after subcutaneous implantation.
Reviewer II: Why do the authors believe that they saw no 
difference in tissue mechanical properties in vitro despite 
differences in ECM accumulation between the different 
groups?
Authors: Extracellular matrix formation, and in particular 
collagen network formation, is a slow process in vitro. 
We have shown before that the mechanical properties 
of the matrix are not only determined by the amount of 
matrix components deposited, but also influenced by 
the cross-links between matrix molecules (i.e. collagen 
cross-links) (Bastiaansen-Jenniskens et al., 2008b). 
Moreover, the addition of TGFβ to chondrocytes has 
previously been demonstrated to result in less collagen 
cross-links in alginate, although it induced collagen 
cross-links in monolayer (Bastiaansen-Jenniskens et al., 
2008a; Jenniskens et al., 2006). The optimal use of TGFβ, 
and maybe the removal of it for a certain period before 
implantation, will be an interesting topic to consider in 
future research.
Reviewer III: The major issue I have with this study 
is how meaningful it is to culture and ‘re-differentiate’ 
articular chondrocytes as if they were a chondro-progenitor 
population. They’ve already negotiated the chondrogenesis 
process.
Authors: We had two reasons for the set-up of our current 
study. 1) It has been previously shown that culture-
expanded chondrocytes that have not been re-differentiated 
in vitro can indeed form cartilage when implanted in vivo. 
Nevertheless, the cartilage formed is not always of good 
quality and will highly depend on the scaffold as well as 
on the cell density used (Marijnissen et al., 2000). In vitro 
re-differentiation, though not necessarily for 5 weeks, 
improves this. 2) Obviously, in order to form cartilage 
in ectopic locations, MSCs need chondrogenic induction 
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in vitro. To be able to compare both chondrocytes and 
MSCs, we decided to expose all cell sources to an identical 
chondrogenic culture medium in vitro, that contained 
TGFβ1. Our experiments nicely confirmed that cartilage 
formation was hugely decreased for all cell sources in a 
subcutaneous environment when cultured without TGFβ1.
Reviewer III: The other interesting aspects of the study 
are the disparities between the matrix protein data and the 
modulus values, and between the hypertrophic marker 
expression and construct mineralisation. Unfortunately 
these disparities undermine the overall value of the 
manuscript.
Authors: There is a good possibility that the biochemical 
data are not directly correlated to the biomechanical data 
in these developing cartilage constructs, since the quality 
of the matrix is not only determined by the amount of 
matrix components deposited, but also influenced by 
the number of cross-links between matrix molecules 
(i.e. collagen cross-links) (Bastiaansen-Jenniskens et 
al., 2008b). Furthermore, we have performed a multiple 
regression analysis for all cell sources separately using only 
GAG and collagen deposition as independent variables. 
Presumably, other components such as the elastic fibre 
network in constructs containing ECs have influence on 
the biomechanical properties in vivo as well, although the 
exact contribution of these components to mechanical 
functionality is not fully understood in the literature.
 We believe the lack of correlation between the 
hypertrophic differentiation and scaffold calcification 
is very interesting and important to realise. It teaches 
us some valuable things for future applications. Firstly, 
we have demonstrated that cell-free alginate constructs 
did mineralise in vivo, which was an unexpected finding 
and obviously not related to hypertrophic differentiation. 
It seemed that less metabolically active (meaning the 
colour of the culture medium was neutral to alkaline) 
alginate constructs were likely to mineralise in vivo. This 
is obviously a typical characteristic of alginate and it is 
very valuable to know because alginate is actually being 
using in (experimental) clinical applications. Furthermore, 
cell-alginate constructs expressing hypertrophic genes in 
vitro, never calcified nor formed bone in vivo. This is a very 
promising outcome and indicates a possible benefit for the 
use of alginate as a cell carrier for cartilage reconstruction.
Reviewer III: On a practical level, considering the 
doubling times, retention of chondrogenic potential, and 
the amount of donor tissue available, which source of 
chondrogenic cells do you think is the superior choice for 
clinical applications?
Authors: At the end of our manuscript we conclude that 
articular chondrocytes possess the highest chondrogenic 
capacity in vitro, while ear and nasal chondrocytes are 
most potent for cartilage regeneration after subcutaneous 
implantation, making them attractive cell sources for future 
cell-based cartilage repair.
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